Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
暂无分享,去创建一个
H. Kliem | B. Berisha | H. Meyer | D. Schams | W. Kraetzl | H. Welter | M. Steffl
[1] B. Berisha,et al. Expression of estrogen and progesterone receptors in the bovine ovary during estrous cycle and pregnancy , 2007, Endocrine.
[2] B. Berisha,et al. Expression of fibroblast growth factor 1 (FGF1) and FGF7 in mature follicles during the periovulatory period after GnRH in the cow. , 2006, The Journal of reproduction and development.
[3] B. Berisha,et al. Changes in fibroblast growth factor 2 and its receptors in bovine follicles before and after GnRH application and after ovulation. , 2006, Reproduction.
[4] M. Moses,et al. Matrix metalloproteinase‐2 (MMP‐2) expression and regulation by tumor necrosis factor alpha (TNFα) in the bovine corpus luteum , 2005 .
[5] T. Curry,et al. Regulation of Matrix Metalloproteinase-19 Messenger RNA Expression in the Rat Ovary1 , 2004, Biology of reproduction.
[6] J. Byström,et al. Plasminogen activator inhibitor‐2 (PAI‐2) in eosinophilic leukocytes , 2004, Journal of leukocyte biology.
[7] B. Berisha,et al. Expression pattern of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) system members in bovine corpus luteum endothelial cells during treatment with FGF-2, VEGF or oestradiol. , 2004, Reproduction in domestic animals = Zuchthygiene.
[8] B. Berisha,et al. Regulation of corpus luteum function in cattle--an overview. , 2004, Reproduction in domestic animals = Zuchthygiene.
[9] B. Berisha,et al. Vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) expression during induced luteolysis in the bovine corpus luteum , 2004, Molecular reproduction and development.
[10] M. Pfaffl,et al. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations , 2004, Biotechnology Letters.
[11] B. Berisha,et al. Involvement of Pro-Inflammatory Cytokines, Mediators of Inflammation, and Basic Fibroblast Growth Factor in Prostaglandin F2α-Induced Luteolysis in Bovine Corpus Luteum1 , 2004, Biology of reproduction.
[12] O. Mueller,et al. RNA Integrity Number ( RIN ) – Standardization of RNA Quality Control Application , 2004 .
[13] L. Wahl,et al. Interferon-γ Differentially Regulates Monocyte Matrix Metalloproteinase-1 and -9 through Tumor Necrosis Factor-α and Caspase 8* , 2003, Journal of Biological Chemistry.
[14] B. Rueda,et al. Microvascular endothelial cells of the corpus luteum , 2003, Reproductive biology and endocrinology : RB&E.
[15] Kui Liu,et al. Expression and regulation of plasminogen activators, plasminogen activator inhibitor type-1, and steroidogenic acute regulatory protein in the rhesus monkey corpus luteum. , 2003, Endocrinology.
[16] K. Osteen,et al. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. , 2003, Endocrine reviews.
[17] B. Berisha,et al. Real‐time changes of the local vasoactive peptide systems (angiotensin, endothelin) in the bovine corpus luteum after induced luteal regression , 2003, Molecular reproduction and development.
[18] H. Endo,et al. Stage‐specific regulatory element of mouse Sry gene , 2003, Molecular reproduction and development.
[19] L. Wahl,et al. Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. , 2003, The Journal of biological chemistry.
[20] W. Murdoch,et al. Role of matrix metalloproteinase 2 in the ovulatory folliculo-luteal transition of ewes. , 2002, Reproduction.
[21] R. Stouffer,et al. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. , 2002, Molecular human reproduction.
[22] M. Moses,et al. Bovine Membrane-Type 1 Matrix Metalloproteinase: Molecular Cloning and Expression in the Corpus Luteum1 , 2002, Biology of reproduction.
[23] T. Ny,et al. Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems , 2002, Molecular and Cellular Endocrinology.
[24] J Frederick Woessner,et al. MMPs and TIMPs—An historical perspective , 2002, Methods in molecular biology.
[25] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[26] J. Laissue,et al. MMP‐19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours , 2001, The Journal of pathology.
[27] H. Shimada,et al. Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. , 2001, Cancer research.
[28] I. Walter,et al. Matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitor-2 of matrix metalloproteinases (TIMP-2) in the placenta and interplacental uterine wall in normal cows and in cattle with retention of fetal membranes. , 2001, Placenta.
[29] R. Rasmussen. Quantification on the LightCycler , 2001 .
[30] R. Einspanier,et al. Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles. , 2000, The Journal of endocrinology.
[31] R. Einspanier,et al. Expression and Tissue Concentration of Vascular Endothelial Growth Factor, Its Receptors, and Localization in the Bovine Corpus Luteum During Estrous Cycle and Pregnancy1 , 2000, Biology of reproduction.
[32] R. Forough,et al. Overexpression of a secretory form of FGF‐1 promotes MMP‐1‐mediated endothelial cell migration , 2000, Journal of cellular biochemistry.
[33] K. Spanel‐Borowski,et al. Difference in localization of eosinophils and mast cells in the bovine ovary. , 2000, Journal of reproduction and fertility.
[34] K. Tanaka,et al. Signal transduction and transcriptional regulation of angiogenesis. , 2000, Advances in experimental medicine and biology.
[35] M. F. Smith,et al. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function. , 2019, Journal of reproduction and fertility. Supplement.
[36] U. Krawinkel,et al. Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium. , 1999, Experimental cell research.
[37] M. Luck,et al. Distribution of extracellular matrix components in the developing ruminant corpus luteum: a wound repair hypothesis for luteinization. , 1999, Journal of reproduction and fertility.
[38] R. Webb,et al. Immune cells and cytokine production in the bovine corpus luteum throughout the oestrous cycle and after induced luteolysis. , 1999, Journal of reproduction and fertility.
[39] L. Wahl,et al. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. , 1998, Journal of immunology.
[40] H. Granger,et al. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[41] E. Keshet,et al. Apposition-dependent induction of plasminogen activator inhibitor type 1 expression: a mechanism for balancing pericellular proteolysis during angiogenesis. , 1998, Blood.
[42] A. Reiner,et al. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. , 1998, Microvascular research.
[43] M A Moses,et al. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. , 1998, Stem cells.
[44] T. Plesner,et al. Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase‐Type Plasminogen Activator Receptor, uPAR , 1997, Stem cells.
[45] Y. Sun,et al. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter , 1997, Molecular and cellular biology.
[46] T. Ny,et al. Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression , 1997, Molecular and Cellular Endocrinology.
[47] S. Mandriota,et al. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. , 1997, Journal of cell science.
[48] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[49] D. Falcone,et al. Role of Laminin in Matrix Induction of Macrophage Urokinase-type Plasminogen Activator and 92-kDa Metalloproteinase Expression* , 1997, The Journal of Biological Chemistry.
[50] Z. Werb,et al. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene , 1996, The Journal of cell biology.
[51] J. Warren,et al. Expression of monocyte chemoattractant protein-1 in the corpus luteum of the rat. , 1996, Biology of reproduction.
[52] Liu Yixun,et al. Studies on the role of plasminogen activators and plasminogen activator inhibitor type-1 in rat corpus luteum of pregnancy. , 1995 .
[53] M. Luck,et al. Gene expression and protein distribution of collagen, fibronectin and laminin in bovine follicles and corpora lutea. , 1995, Journal of reproduction and fertility.
[54] Q. Feng,et al. Studies on the role of plasminogen activators and plasminogen activator inhibitor type-1 in rat corpus luteum of pregnancy. , 1995, Biology of reproduction.
[55] M. Gyetko,et al. Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. , 1994, Blood.
[56] R. Norman,et al. Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. , 1994, Fertility and sterility.
[57] M. F. Smith,et al. Pattern of protein production by bovine corpora lutea during luteolysis and characterization of expression of two major secretory products of regressing corpora lutea. , 1994, Journal of reproduction and fertility.
[58] M. Luck,et al. Identification and measurement of collagen in the bovine corpus luteum and its relationship with ascorbic acid and tissue development. , 1993, Journal of reproduction and fertility.
[59] Feng Qiang,et al. The possible involvement of tissue type plasminogen activator in luteolysis of rhesus monkey , 1993 .
[60] S. Shapiro,et al. Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. , 1993, The Journal of biological chemistry.
[61] Q. Feng,et al. The possible involvement of tissue type plasminogen activator in luteolysis of rhesus monkey. , 1993, Human reproduction.
[62] E. Bauer,et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells , 1992, Journal of cellular physiology.
[63] E. Keshet,et al. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[64] B. Chew,et al. Quantitative and Qualitative Changes in Blood Leukocytes in the Porcine Ovary , 1991, American journal of reproductive immunology.
[65] W. Murdoch,et al. Investigations Concerning the Relationship of Ovarian Eosinophilia to Ovulation and Luteal Function in the Sheep , 1991, American journal of reproductive immunology.
[66] D. Sugarbaker,et al. Developmental expression of plasminogen activator inhibitor type 1 by human alveolar macrophages. Possible role in lung injury. , 1990, Journal of immunology.
[67] A. Eisen,et al. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. , 1990, The Journal of clinical investigation.
[68] L. Orci,et al. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes , 1990, The Journal of cell biology.
[69] J. Woessner,et al. Connective tissue breakdown in ovulation , 1989, Steroids.
[70] P. Hart,et al. Human monocytes can produce tissue-type plasminogen activator , 1989, The Journal of experimental medicine.
[71] H. Remold,et al. IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes. , 1988, Journal of immunology.
[72] E. Schallenberger,et al. Development of a sensitive enzymeimmunoassay (EIA) for progesterone determination in unextracted bovine plasma using the second antibody technique. , 1987, Journal of steroid biochemistry.